We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.78B
AUM Growth
-$305M
(-4.3%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-15.36%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
1,363
New
346
Increased
312
Reduced
313
Closed
357
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$251M |
| 2 |
AGN
Allergan plc
AGN
|
+$209M |
| 3 |
Cigna
CI
|
+$106M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$77.7M |
| 5 |
Labcorp
LH
|
+$52.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$368M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$354M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$331M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$224M |
| 5 |
Brookdale Senior Living
BKD
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.37% |
| 2 | Consumer Discretionary | 6.42% |
| 3 | Industrials | 5.53% |
| 4 | Financials | 5.32% |
| 5 | Technology | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVCN
176
DELISTED
Neovasc Inc.
NVCN
| $8.12M | 0.12% |
+36
| New | +$7.87M |
|
177
Constellium
CSTM
$4.02B
| $8.1M | 0.12% |
+398,400
| New | +$7.48M |
|
|
PFNX
178
DELISTED
Pfenex Inc.
PFNX
| $8.09M | 0.12% |
+507,520
| New | +$5.59M |
|
|
VTLE
179
DELISTED
Vital Energy
VTLE
| $8.08M | 0.12% |
+30,976
| New | +$7.04M |
|
180
Xenon Pharmaceuticals
XENE
$6.19B
| $8.01M | 0.12% |
475,000
+25,000
| +6% | +$462K |
|
|
CLNY
181
DELISTED
Colony Capital, Inc.
CLNY
| $7.96M | 0.12% |
307,303
+81,171
| +36% | +$2.03M |
|
|
AVIV
182
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
| $7.88M | 0.12% |
216,023
+1,259
| +0.6% | +$46.6K |
|
183
Carlisle Companies
CSL
$15.3B
| $7.87M | 0.12% |
85,000
+13,971
| +20% | +$1.29M |
|
|
INVX
184
Innovex International
INVX
$2.21B
| $7.87M | 0.12% |
+115,002
| New | +$8.29M |
|
185
Vermilion Energy
VET
$1.69B
| $7.81M | 0.12% |
185,728
+159,823
| +617% | +$7.02M |
|
186
SunCoke Energy
SXC
$753M
| $7.58M | 0.11% |
506,973
+124,412
| +33% | +$2.12M |
|
187
Canadian Solar
CSIQ
$1.11B
| $7.51M | 0.11% |
225,000
+99,200
| +79% | +$2.74M |
|
188
Flowserve
FLS
$10.2B
| $7.36M | 0.11% |
177,932
-45,610
| -20% | -$2.65M |
|
|
VIRX
189
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $7.35M | 0.11% |
14,286
+7,008
| +96% | +$3.54M |
|
190
Teva Pharmaceuticals
TEVA
$40.1B
| $7.32M | 0.11% |
117,490
-127,574
| -52% | -$7.42M |
|
191
AngloGold Ashanti
AU
$41.2B
| $7.2M | 0.11% |
+771,300
| New | +$8.26M |
|
192
AMC Global Media
AMCX
$501M
| $7.14M | 0.11% |
93,158
+70,443
| +310% | +$4.87M |
|
193
James River Group Holdings
JRVR
$213M
| $7.12M | 0.11% |
302,620
-3,541
| -1% | -$79.1K |
|
194
Lockheed Martin
LMT
$136B
| $7.1M | 0.1% |
35,000
+30,924
| +759% | +$6.11M |
|
|
LTM
195
DELISTED
LIFE TIME FITNESS INC
LTM
| $7.09M | 0.1% |
+99,925
| New | +$6.01M |
|
|
ETFC
196
DELISTED
E*Trade Financial Corporation
ETFC
| $7.06M | 0.1% |
247,273
+10,515
| +4% | +$268K |
|
|
CTB
197
DELISTED
Cooper Tire & Rubber Co.
CTB
| $6.98M | 0.1% |
+163,007
| New | +$6.02M |
|
|
SUSQ
198
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $6.88M | 0.1% |
501,626
-1,643
| -0.3% | -$21.9K |
|
199
Wabtec
WAB
$50.5B
| $6.76M | 0.1% |
+71,136
| New | +$6.42M |
|
200
Dave & Buster's
PLAY
$369M
| $6.75M | 0.1% |
221,651
+167,776
| +311% | +$5.02M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Visium Asset Management held 1,363 positions worth $6.78B, down 4.3% from $7.08B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management withdrew a net $1.04B in Q1 2015, closing 357 positions and reducing 313 holdings. Its most notable exit was Allergan Inc, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Visium Asset Management opened a new position in Akorn Inc worth $25.3M.
- Visium Asset Management's largest Q1 2015 buy was Akorn Inc: 533,000 shares worth $25.3M.
- Visium Asset Management added most to Perrigo in Q1 2015, an estimated $251M increase.
- Visium Asset Management's biggest Q1 2015 reduction was Endo International plc, cutting an estimated $331M.
- Visium Asset Management fully exited Allergan Inc in Q1 2015, selling an estimated $368M.
- Visium Asset Management's ten largest holdings make up 29% of its $6.78B portfolio in Q1 2015.
- Visium Asset Management opened 346 new positions and closed 357 in Q1 2015.
- Visium Asset Management's portfolio value fell 4.3% quarter-over-quarter to $6.78B.
Based on Visium Asset Management's 13F filing for Q1 2015, filed 15 May 2015.